Αποτελέσματα Αναζήτησης
R53.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM R53.1 became effective on October 1, 2024. This is the American ICD-10-CM version of R53.1 - other international versions of ICD-10 R53.1 may differ.
- Weak, Weakening, Weakness
Search All ICD-10 Toggle Dropdown. Search All ICD-10;...
- Radiculopathy
neuralgia and neuritis NOS (M79.2); radiculopathy with...
- Weak, Weakening, Weakness
M62.81 is a billable diagnosis code used to specify a medical diagnosis of muscle weakness (generalized). The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2024 through September 30, 2025. Approximate Synonyms.
M62.81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM M62.81 became effective on October 1, 2024. This is the American ICD-10-CM version of M62.81 - other international versions of ICD-10 M62.81 may differ.
15 Ιαν 2020 · Patients with proximal (limb-girdle) weakness may have difficulty rising from a chair, climbing stairs, or lifting their arms overhead to perform activities of daily living (e.g., combing...
Get crucial instructions for accurate ICD-10-CM M62.81 coding with all applicable Excludes 1 and Excludes 2 notes from the section level conveniently shown with each code.
1 Οκτ 2024 · M62.81 is a valid billable ICD-10 diagnosis code for Muscle weakness (generalized). It is found in the 2025 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2024 - Sep 30, 2025. ↓ See below for any exclusions, inclusions or special notations. Excludes1.
PMCID: PMC10360994 PMID: 37483534. Abstract. Proximal myopathy presents as generalized muscle weakness commonly involving the muscles of upper and/or lower limbs. Toxins, long-term use of statins, corticosteroids, alcohol, SGLT2 inhibitors, COVID-19 vaccination, and antimalarials have been attributed to its development.
